Stock Track | Neogen Corp Soars 5.58% Following Q3 Earnings and Maintained "Buy" Rating

Stock Track

Apr 10, 2025

Neogen Corp (NASDAQ: NEOG) shares are soaring 5.58% in Thursday's trading session, following the company's third-quarter fiscal year 2025 earnings report and a maintained "Buy" rating from Guggenheim. Despite facing macroeconomic challenges, investors appear encouraged by management's plans to address issues and focus on key growth areas.

The company reported Q3 revenue of $221 million, with core revenue growth of 20 basis points. While this fell short of expectations, Neogen's Food Safety segment showed resilience, growing 7% excluding sample handling challenges. Management highlighted progress in integrating their transformational acquisition and plans to accelerate building a more profitable, focused business. The company also successfully refinanced its Term Loan A, extending maturity and realizing interest rate savings.

Looking ahead, Neogen is taking steps to align its cost structure with current revenue levels and focusing on its differentiated bovine genomics offering. The company's maintained "Buy" rating from Guggenheim suggests analyst confidence in Neogen's long-term prospects. While macroeconomic uncertainties and potential tariff impacts remain concerns, investors seem optimistic about Neogen's strategic initiatives and its position in the critical food safety diagnostics market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1127204261"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1127204261\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1127204261?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-10 22:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127204261","market":"sg","top_or_hot":-1,"title":"Stock Track | Neogen Corp Soars 5.58% Following Q3 Earnings and Maintained \"Buy\" Rating","media":"Stock Track","content":"<p>Neogen Corp (NASDAQ: NEOG) shares are soaring 5.58% in Thursday's trading session, following the company's third-quarter fiscal year 2025 earnings report and a maintained \"Buy\" rating from Guggenheim. Despite facing macroeconomic challenges, investors appear encouraged by management's plans to address issues and focus on key growth areas.</p>\n\n<p>The company reported Q3 revenue of $221 million, with core revenue growth of 20 basis points. While this fell short of expectations, Neogen's Food Safety segment showed resilience, growing 7% excluding sample handling challenges. Management highlighted progress in integrating their transformational acquisition and plans to accelerate building a more profitable, focused business. The company also successfully refinanced its Term Loan A, extending maturity and realizing interest rate savings.</p>\n\n<p>Looking ahead, Neogen is taking steps to align its cost structure with current revenue levels and focusing on its differentiated bovine genomics offering. The company's maintained \"Buy\" rating from Guggenheim suggests analyst confidence in Neogen's long-term prospects. While macroeconomic uncertainties and potential tariff impacts remain concerns, investors seem optimistic about Neogen's strategic initiatives and its position in the critical food safety diagnostics market.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Neogen Corp Soars 5.58% Following Q3 Earnings and Maintained \"Buy\" Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Neogen Corp Soars 5.58% Following Q3 Earnings and Maintained \"Buy\" Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-04-10 22:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Neogen Corp (NASDAQ: NEOG) shares are soaring 5.58% in Thursday's trading session, following the company's third-quarter fiscal year 2025 earnings report and a maintained \"Buy\" rating from Guggenheim. Despite facing macroeconomic challenges, investors appear encouraged by management's plans to address issues and focus on key growth areas.</p>\n\n<p>The company reported Q3 revenue of $221 million, with core revenue growth of 20 basis points. While this fell short of expectations, Neogen's Food Safety segment showed resilience, growing 7% excluding sample handling challenges. Management highlighted progress in integrating their transformational acquisition and plans to accelerate building a more profitable, focused business. The company also successfully refinanced its Term Loan A, extending maturity and realizing interest rate savings.</p>\n\n<p>Looking ahead, Neogen is taking steps to align its cost structure with current revenue levels and focusing on its differentiated bovine genomics offering. The company's maintained \"Buy\" rating from Guggenheim suggests analyst confidence in Neogen's long-term prospects. While macroeconomic uncertainties and potential tariff impacts remain concerns, investors seem optimistic about Neogen's strategic initiatives and its position in the critical food safety diagnostics market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NEOG","symbol_name":"纽尔真检测","start_time":0,"source_url":"","article_id":"1127204261","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127204261","pubTimestamp":1744295098,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Neogen Corp  shares are soaring 5.58% in Thursday's trading session, following the company's third-quarter fiscal year 2025 earnings report and a maintained \"Buy\" rating from Guggenheim. Despite facing macroeconomic challenges, investors appear encouraged by management's plans to address issues and focus on key growth areas.The company reported Q3 revenue of $221 million, with core revenue growth of 20 basis points. While this fell short of expectations, Neogen's Food Safety segment showed resil","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NEOG":"纽尔真检测"},"translate_title":"股票赛道Neogen Corp第三季度财报公布后飙升5.58%，维持“买入”评级","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NEOG":1},"content_text":"Neogen Corp (NASDAQ: NEOG) shares are soaring 5.58% in Thursday's trading session, following the company's third-quarter fiscal year 2025 earnings report and a maintained \"Buy\" rating from Guggenheim. Despite facing macroeconomic challenges, investors appear encouraged by management's plans to address issues and focus on key growth areas.\nThe company reported Q3 revenue of $221 million, with core revenue growth of 20 basis points. While this fell short of expectations, Neogen's Food Safety segment showed resilience, growing 7% excluding sample handling challenges. Management highlighted progress in integrating their transformational acquisition and plans to accelerate building a more profitable, focused business. The company also successfully refinanced its Term Loan A, extending maturity and realizing interest rate savings.\nLooking ahead, Neogen is taking steps to align its cost structure with current revenue levels and focusing on its differentiated bovine genomics offering. The company's maintained \"Buy\" rating from Guggenheim suggests analyst confidence in Neogen's long-term prospects. While macroeconomic uncertainties and potential tariff impacts remain concerns, investors seem optimistic about Neogen's strategic initiatives and its position in the critical food safety diagnostics market.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}